HighTower Advisors’s ADMA Biologics ADMA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $640K | Buy |
35,156
+4,948
| +16% | +$90.1K | ﹤0.01% | 2314 |
|
2025
Q1 | $599K | Sell |
30,208
-69,173
| -70% | -$1.37M | ﹤0.01% | 2304 |
|
2024
Q4 | $1.7M | Buy |
99,381
+11,910
| +14% | +$204K | ﹤0.01% | 1612 |
|
2024
Q3 | $1.75M | Buy |
87,471
+25,492
| +41% | +$509K | ﹤0.01% | 1600 |
|
2024
Q2 | $692K | Sell |
61,979
-11,010
| -15% | -$123K | ﹤0.01% | 2084 |
|
2024
Q1 | $482K | Buy |
72,989
+1,569
| +2% | +$10.4K | ﹤0.01% | 2299 |
|
2023
Q4 | $326K | Sell |
71,420
-1,097
| -2% | -$5.01K | ﹤0.01% | 2623 |
|
2023
Q3 | $258K | Buy |
72,517
+38,160
| +111% | +$136K | ﹤0.01% | 2703 |
|
2023
Q2 | $126K | Sell |
34,357
-300
| -0.9% | -$1.1K | ﹤0.01% | 2997 |
|
2023
Q1 | $114K | Buy |
34,657
+12,434
| +56% | +$40.9K | ﹤0.01% | 2883 |
|
2022
Q4 | $86K | Buy |
22,223
+600
| +3% | +$2.32K | ﹤0.01% | 2914 |
|
2022
Q3 | $53K | Buy |
+21,623
| New | +$53K | ﹤0.01% | 2827 |
|
2021
Q2 | – | Sell |
-12,360
| Closed | -$22K | – | 2897 |
|
2021
Q1 | $22K | Buy |
+12,360
| New | +$22K | ﹤0.01% | 2814 |
|